Doxorubicin Hydrochloride

盐酸多柔比星

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameDoxorubicin Hydrochloride
Drug Alias NameDoxorubicine Hydrochloride盐酸阿霉素Chloridrato de Doxorrubicina亚德里亚霉素Doxorubicina Hydrochloride +[28] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsBone metastasesSolid tumoursBrain Neoplasms +[14] 
Global Approved IndicationsNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesThermosome GmbHPfizer IncSohag University +[9] 
Inactive CompaniesChildren'S National Research InstituteIRCCS Azienda Ospedaliero-Universitaria di BolognaTlc Biopharmaceuticals Bv
Active IndicationsSolid tumoursBrain NeoplasmsBreast Neoplasms +[6] 
Inactive IndicationsBone metastasesOvarian NeoplasmsLiver Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG